Skip to content

Clinical trials

Phase 3 Osteoporosis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Osteoporosis Phase: Phase 3 Country / region: United Kingdom Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20062
20081
20101
20122
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Amgen2
Ligand Pharmaceuticals1
Sheffield Teaching Hospitals NHS Foundation Trust1
University College, London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Osteoporosis8
Bone Diseases2
Bone Diseases, Metabolic2
Muscular Dystrophy, Duchenne2
Musculoskeletal Diseases2
Osteoporosis, Postmenopausal2
Anemia1
Hot Flashes1
Prostatic Neoplasms1
Spinal Fractures1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.